Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice

Virus Research

Volumn 108, Issue 1-2, 2005, Pages 149-159

  Toth, Karoly ^a   Doronin, Konstantin ^a   Kuppuswamy, Mohan ^a   Ward, Peter ^a   Tollefson, Ann E ^a   Wold, William S M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; E3 protein; Immunocompetent

Indexed keywords

ADENOVIRUS PROTEIN E3; ADENOVIRUS VECTOR; DEATH RECEPTOR 4; FAS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL SURFACE; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC TRANSCRIPTION; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS GENE;

ADENOVIRUS E3 PROTEINS; ADENOVIRUSES, HUMAN; ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; FEMALE; GENETIC VECTORS; GRAFT REJECTION; HUMANS; IMMUNOCOMPETENCE; IMMUNOSUPPRESSION; MICE; MICE, INBRED C57BL; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTS;

EID: 12844264160     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.09.001     Document Type: Article

References (66)

1. M. Andersson, A. McMichael, and P.A. Peterson Reduced allorecognition of adenovirus-2 infected cells J. Immunol. 138 1987 3960 3966
2. M. Andersson, S. Pääbo, T. Nilsson, and P.A. Peterson Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance Cell 43 1985 215 222
3. C. Benedict, P. Norris, T. Prigozy, J.L. Bodmer, J.A. Mahr, C. Garnett, F. Martinon, J. Tschopp, L.R. Gooding, and C.F. Ware Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and-2 J. Biol. Chem. 276 2001 3270 3278
4. A.J. Bett, W. Haddara, L. Prevec, and F.L. Graham An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3 Proc. Natl. Acad. Sci. U. S. A. 91 1994 8802 8806
5. B.M. Bhat, and W.S.M. Wold Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants J. Virol. 60 1986 54 63
6. M.A. Brach, S.M. Kharbanda, F. Herrmann, and D.W. Kufe Activation of the transcription factor kappa B in human KG-1 myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine Mol. Pharmacol. 41 1992 60 63
7. H.A. Brady, A. Scaria, and W.S.M. Wold Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus J. Virol. 66 1992 5914 5923
8. H.A. Brady, and W.S.M. Wold Competition between splicing and polyadenylation reactions determines which adenovirus region E3 mRNAs are synthesized Mol. Cell. Biol. 8 1988 3291 3297
9. J.T. Bruder, T. Jie, D.L. McVey, and I. Kovesdi Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver J. Virol. 71 1997 7623 7628
10. H.-G. Burgert, and S. Kvist An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens Cell 41 1985 987 997
11. H.-G. Burgert, J.L. Maryanski, and S. Kvist "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens Proc. Natl. Acad. Sci. U. S. A. 84 1987 1356 1360
12. P. Chen, J. Tian, I. Kovesdi, and J.B. Bruder Interaction of the adenovirus 14.7K protein with FLICE inhibits Fas ligand-induced apoptosis J. Biol. Chem. 273 1998 5815 5820
13. C. Cladaras, B. Bhat, and W.S. Wold Mapping the 5′ ends, 3′ ends, and splice sites of mRNAs from the early E3 transcription unit of adenovirus 5 Virology 140 1985 44 54
14. C. Cladaras, and W.S. Wold DNA sequence of the early E3 transcription unit of adenovirus 5 Virology 140 1985 28 43
15. J.H. Cox, J.W. Yewdell, L.C. Eisenlohr, P.R. Johnson, and J.R. Bennink Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum Science 247 1990 715 718
16. T. Dimitrov, P. Krajcsi, T.W. Hermiston, A.E. Tollefson, M. Hannink, and W.S.M. Wold Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes J. Virol. 71 1997 2830 2837
17. K. Doronin, M. Kuppuswamy, K. Toth, A.E. Tollefson, P. Krajcsi, V. Krougliak, and W.S.M. Wold Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy J. Virol. 75 2001 3314 3324
18. K. Doronin, K. Toth, M. Kuppuswamy, P. Krajcsi, A.E. Tollefson, and W.S.M. Wold Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus Virology 305 2003 378 387
19. K. Doronin, K. Toth, M. Kuppuswamy, P. Ward, A.E. Tollefson, and W.S.M. Wold Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein J. Virol. 74 2000 6147 6155
20. S. Efrat, G. Fejer, M. Brownlee, and M.S. Horwitz Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes Proc. Natl. Acad. Sci. U. S. A. 92 1995 6947 6951
21. S. Efrat, D. Serreze, A. Svetlanov, C.M. Post, E.A. Johnson, K. Herold, and M. Horwitz Adenovirus early region 3 (E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice Diabetes 50 2001 980 984
22. A. Elsing, and H.-G. Burgert The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization Proc. Natl. Acad. Sci. U. S. A. 95 1998 10072 10077
23. J.M. Friedman, and M.S. Horwitz Inhibition of tumor necrosis factor alpha-induced NF-kB activation by the adenovirus E3-10.4/14.5K complex J. Virol. 76 2002 5515 5521
24. H.S. Ginsberg, R.L. Horswood, R.M. Chanock, and G.A. Prince Role of early genes in pathogenesis of adenovirus pneumonia Proc. Natl. Acad. Sci. U. S. A. 87 1990 6191 6195
25. H.S. Ginsberg, U. Lundholm-Beauchamp, R.L. Horswood, B. Pernis, W.S.M. Wold, R.M. Chanock, and G.A. Prince Role of early region 3 (E3) in pathogenesis of adenovirus disease Proc. Natl. Acad. Sci. U. S. A. 86 1989 3823 3827
26. L.R. Gooding, L.W. Elmore, A.E. Tollefson, H.A. Brady, and W.S.M. Wold A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor Cell 53 1988 341 346
27. L.R. Gooding, T.S. Ranheim, A.E. Tollefson, L. Aquino, P. Duerksen-Hughes, T.M. Horton, and W.S.M. Wold The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor J. Virol. 65 1991 4114 4123
28. L.R. Gooding, and W.S.M. Wold Molecular mechanisms by which adenoviruses counteract antiviral immune defenses Crit. Rev. Immunol. 10 1990 53 71
29. T.S. Griffith, C.T. Rauch, P.J. Smolak, J.Y. Waugh, N. Boiani, D.H. Lynch, C.A. Smith, R.G. Goodwin, and M.Z. Kubin Functional analysis of TRAIL receptors using monoclonal antibodies J. Immunol. 162 1999 2597 2605
30. K.S. Harrod, T.W. Hermiston, B.C. Trapnell, W.S.M. Wold, and J.A. Whitsett Lung-specific expression of E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression Hum. Gene Ther. 9 1998 1885 1898
31. K.S. Harrod, and A.D.W.J.A. Mounday Adeno E3-14.7K protein in LPS-induced lung inflammation Am. J. Physiol. Lung Cell. Mol. Physiol. 278 2000 631 639
32. L.K. Hawkins, and W.S.M. Wold A 12,500 MW protein is coded by region E3 of adenovirus Virology 188 1992 486 494
33. T.W. Hermiston, R.A. Tripp, T. Sparer, L.R. Gooding, and W.S.M. Wold Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes J. Virol. 67 1993 5289 5298
34. T.M. Horton, T.S. Ranheim, L. Aquino, D.I. Kusher, S.K. Saha, C.F. Ware, W.S.M. Wold, and L.R. Gooding Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis J. Virol. 65 1991 2629 2639
35. T.M. Horton, A.E. Tollefson, W.S.M. Wold, and L.R. Gooding A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes J. Virol. 64 1990 1250 1255
36. M. Horwitz Adenovirus immunoregulatory genes and their cellular targets Virology 279 2001 1 8
37. Y. Ilan, G. Droguett, N.R. Chowdhury, Y. Li, K. Sengupta, N.R. Thummala, A. Davidson, J.R. Chowdhury, and M.S. Horwitz Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression Proc. Natl. Acad. Sci. U. S. A. 94 1997 2587 2592
38. P. Krajcsi, T. Dimitrov, T.W. Hermiston, A.E. Tollefson, T.S. Ranheim, S.B. Vande Pol, A.H. Stephenson, and W.S.M. Wold The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid J. Virol. 70 1996 4904 4913
39. A.M. Lesokhin, F. Delgado-Lopez, and M.S. Horwitz Inhibition of chemokine expression by adenovirus early region three (E3) genes J. Virol. 76 2002 8236 8243
40. D.L. Lichtenstein, K. Toth, K. Doronin, A.E. Tollefson, and W.S. Wold Functions and mechanisms of action of the adenovirus E3 proteins Int. Rev. Immunol. 23 2004 75 111
41. J.A. Mahr, and L.R. Gooding Immune evasion by adenoviruses Immunol. Rev. 168 1999 121 130
42. A.R. Moise, J.R. Grant, T.Z. Vitalis, and W.A. Jefferies Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release J. Virol. 76 2002 1578 1587
43. J.E. Nelson, and M.A. Kay Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication J. Virol. 71 1997 8902 8907
44. D.L. Paterson, N. Singh, A. Panebianco, C.F. Wannstedt, M.M. Wagener, T. Gayowski, and I.R. Marino Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil Transplantation 66 1998 593 598
45. M.A. Pierce, H.D. Chapman, C.M. Post, A. Svetlanov, S. Efrat, M.S. Horwitz, and D.V. Serreze Adenovirus early region 3 antiapoptotic 10.4K, 14.5K, and 14.7K genes decrease the incidence of autoimmune diabetes in NOD mice Diabetes 52 2003 1119 1127
46. F.C. Rawle, A.E. Tollefson, W.S.M. Wold, and L.R. Gooding Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K J. Immunol. 143 1989 2031 2037
47. A. Scaria, A.E. Tollefson, S.K. Saha, and W.S.M. Wold The E3-11.6K protein of adenovirus is an Asn-glycosylated integral membrane protein that localizes to the nuclear membrane Virology 191 1992 743 753
48. D.B. Schowalter, J.C. Tubb, M. Liu, C.B. Wilson, and M.A. Kay Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo Gene Ther. 4 1997 351 360
49. J. Shisler, C. Yang, B. Walter, C.F. Ware, and L.R. Gooding The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis J. Virol. 71 1997 8299 8306
50. T. Sparer, R.A. Tripp, D.L. Dillehay, T.W. Hermiston, W.S.M. Wold, and L.R. Gooding The role of adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model J. Virol. 70 1996 2431 2439
51. P. Stern, M. Gidlund, A. Orn, and H. Wigzell Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC Nature 285 1980 341 342
52. A.R. Stewart, A.E. Tollefson, P. Krajcsi, S.P. Yei, and W.S.M. Wold The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane J. Virol. 69 1995 172 181
53. C.M. Thiagarajan, D. Divakar, and S.J. Thomas Malignancies in renal transplant recipients Transplant. Proc. 30 1998 3154 3155
54. A.E. Tollefson, T.W. Hermiston, D.L. Lichtenstein, C.F. Colle, R.A. Tripp, T. Dimitrov, K. Toth, C.E. Wells, P.C. Doherty, and W.S.M. Wold Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells Nature 392 1998 726 730
55. A.E. Tollefson, P. Krajcsi, M.H. Pursley, L.R. Gooding, and W.S.M. Wold A 14,500 MW protein is coded by region E3 of group C human adenoviruses Virology 175 1990 19 29
56. A.E. Tollefson, P. Krajcsi, S.P. Yei, C.R. Carlin, and W.S.M. Wold A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus J. Virol. 64 1990 794 801
57. A.E. Tollefson, J.S. Ryerse, A. Scaria, T.W. Hermiston, and W.S.M. Wold The E3-11.6 kDa Adenovirus Death Protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants Virology 220 1996 152 162
58. A.E. Tollefson, A. Scaria, T.W. Hermiston, J.S. Ryerse, L.J. Wold, and W.S.M. Wold The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells J. Virol. 70 1996 2296 2306
59. A.E. Tollefson, A. Scaria, S.K. Saha, and W.S.M. Wold The 11,600 MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection J. Virol. 66 1992 3633 3642
60. A.E. Tollefson, K. Toth, K. Doronin, M. Kuppuswamy, O.A. Doronina, D.L. Lichtenstein, T.W. Hermiston, C.A. Smith, and W.S.M. Wold Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins J. Virol. 75 2001 8875 8887
61. A.E. Tollefson, and W.S.M. Wold Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses J. Virol. 62 1988 33 39
62. K. Toth, M. Kuppuswamy, K. Doronin, O.A. Doronina, D.L. Lichtenstein, A.E. Tollefson, and W.S.M. Wold Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region Virology 301 2002 99 108
63. J. Tufariello, S. Cho, and M.S. Horwitz The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model J. Virol. 68 1994 453 462
64. M.G. von Herrath, S. Efrat, M.B.A. Oldstone, and M.S. Horwitz Expression of adenovirus E3 transgenes in b cells prevents autoimmune diabetes Proc. Natl. Acad. Sci. U. S. A. 94 1997 9808 9813
65. J. Wilson-Rawls, and W.S.M. Wold The E3-6.7K protein of adenovirus is an Asn-linked integral membrane glycoprotein localized in the endoplasmic reticulum Virology 195 1993 6 15
66. W.S.M. Wold, A.E. Tollefson, and T.W. Hermiston E3 transcription unit of adenovirus W. Doerfler P. Bohm The Molecular Repertoire of Adenoviruses 1995 Springer-Verlag Heidelberg 237 274